Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation.
In July 1985, all coagulation factor concentrates were withdrawn from the market in Italy and replaced with virally inactivated concentrates. A retrospective survey comparing the prevalence of the antibody to the hepatitis C virus (anti-HCV) in hemophiliacs multitransfused with nonvirally inactivated concentrates until 1985 with that in previously untreated hemophiliacs transfused exclusively with virally inactivated concentrates since 1985 has been conducted in 9 Italian hemophilia centers. The centers, which follow about one-fourth of all the Italian hemophiliacs, provided information about 708 patients infused for the first time before 1985 (group A) and 80 patients infused for the first time between 1985 and 1991 (group B). The prevalence of anti-HCV was 83% (591/708) in group A and 6% (5/80) in group B. For the 5 anti-HCV-seropositive patients from group B, dry heating, hydrophobic interaction chromatography plus dry heating (2 patients), hot vapor and pasteurization were the virucidal methods used for the concentrates implicated in HCV transmission. In the case associated with pasteurization, there is the possibility of intrafamilial transmission of HCV. It appears from this retrospective analysis that there has been a substantial reduction in the risk of HCV transmission since the adoption of virucidal methods. However, these methods do not eliminate completely the risk, which might be further reduced by the recent adoption of anti-HCV screening for plasma donations used to manufacture concentrates.
Morfini
M
M
Department of Hematology and Hemophilia Center, Careggi Hospital, Firenze, Italy.
Mannucci
P M
PM
Ciavarella
N
N
Schiavoni
M
M
Gringeri
A
A
Rafanelli
D
D
Di Bona
E
E
Chistolini
A
A
Tagliaferri
A
A
Rodorigo
G
G
D001779:Blood Coagulation Factors / Q000302:isolation & purification*; D005069:Evaluation Studies as Topic; D006467:Hemophilia A / Q000821:virology*; D002836:Hemophilia B / Q000821:virology*; D006526:Hepatitis C / Q000453:epidemiology* / Q000635:transmission; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors
D001779:Blood Coagulation Factors